You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Reliance submits proposal for potential coronavirus drug Niclosamide

The drug regulator will now evaluate the proposal for public use.

Topics
Reliance Industries | Coronavirus | Coronavirus Tests

Press Trust of India  |  New Delhi 

Reliance Industries, RIL
Photo: Shutterstock

Ltd's R&D arm has proposed the use of Niclosamide - the drug used to treat tapeworm infestation - for treating COVID-19 patients.

Niclosamide, a drug on the World Health Organisation's list of essential medicines, has been used to treat tapeworm infestation for more than 50 years. The oral antiviral drug was also used to treat patients during the SARS outbreak of 2003-04.

"The company submitted a proposal for the application of Niclosamide as a potential drug against COVID-19," the firm's latest annual report said.

The drug regulator will now evaluate the proposal for public use.

The company however did not say if it plans to manufacture the drug or would use it to treat COVID patients at hospitals run by the group.

The Indian government has already given clearance for the Phase 2 clinical trials of Niclosamide in COVID-19 treatment in adult patients.

The Reliance R&D (research and development) team is also working with various Council of Scientific & Industrial Research (CSIR) laboratories to certify Nexar polymer, which has been found to be effective in destroying the lipid layer of various viruses and bacteria.

Leveraging its intellectual capital to help the nation tackle the COVID-19 crisis, Reliance has developed novel cost-effective diagnostic kits called 'R-Green' and 'R-Green Pro' for COVID-19 detection. Both kits have received approval from the Indian Council of Medical Research (ICMR).

The company has also designed a process to produce sanitisers aligned with World Health Organization (WHO) specifications at 20 per cent of the market rate.

"Reliance is working to address insufficient ventilator supply in emergency rooms across hospitals in India by deploying a concept developed in Italy, which enables CPAP machine with a 3D-printed charlotte valve and special snorkelling mask," the report said.

Seeing a significant rise in demand for onsite oxygen as the pandemic raged, Reliance has started working on a value-engineered robust design for oxygen generators capable of producing 5-7 litres of oxygen per minute with a purity of 90-95 per cent.

"Reliance has more than 900 researchers and scientists from world's top institutes working on developing next-gen technology solutions to solve some of the most pressing Indian and global challenges," the annual report said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, June 03 2021. 17:20 IST
RECOMMENDED FOR YOU